| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 10 Aug 2026 | 3 Aug 2026 |
| Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Un-Audited Financial Results (Standalone) for the first quarter ended on June 30th 2026. Pursuant to Regulation 33 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have enclosed herewith: 1. Unaudited Financial Results for the First quarter ended June 30, 2026, duly approved and taken on record by the Board of Directors at its meeting held today i.e. Monday, August 10, 2026. 2. Limited Review Report on the aforesaid results from Statutory Auditors of the Company, as placed before the Board of Directors of the Company in its meeting held today. (As Per BSE Announcement Dated on:10.08.2026) | ||
| Board Meeting | 1 Aug 2026 | 1 Aug 2026 |
| Outcome of the Meeting of the Board of Directors held on August 1, 2026 under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Appointment of Cost Auditor, Internal Auditor and Secretarial Auditor and Discontinuance of Secretarial Auditor | ||
| Board Meeting | 29 May 2026 | 20 May 2026 |
| Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Financial Results (Standalone ) for the quarter and financial year ended 31st March 2026 along with the Audit Report thereon | ||
| Board Meeting | 27 Apr 2026 | 27 Apr 2026 |
| Outcome of Board Meeting - Appointment of Chief Financial Officer (CFO) of the Company pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. | ||
| Board Meeting | 18 Apr 2026 | 18 Apr 2026 |
| Outcome of Board Meeting held on 18 April 2026 under regulation 30 of Sebi(Lodr) Regulations 2015 - Change in Management | ||
| Board Meeting | 4 Apr 2026 | 4 Apr 2026 |
| Intimation of change of management under regulation 30 of SEBI LODR 2015 | ||
| Board Meeting | 16 Feb 2026 | 16 Feb 2026 |
| Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Modification in Postal Ballot Notice | ||
| Board Meeting | 14 Feb 2026 | 7 Feb 2026 |
| Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve Board Meeting intimation for consider and approve the un-audited(standalone) Financial Results for the quarter and nine months ended on 31st December 2025 Board Meeting outcome (As per BSE Announcement dated on: 14.02.2026) | ||
| Board Meeting | 7 Jan 2026 | 7 Jan 2026 |
| Intimation under regulation 30 of SEBI(LODR) regulations,2015-appointment of chief financial officer(CFO), Key Managerial Personnel | ||
| Board Meeting | 29 Dec 2025 | 29 Dec 2025 |
| Announcement under regulation 30 of SEBI(Listing Obligation and Disclosure Requirements) Regulations 2015. | ||
| Board Meeting | 2 Dec 2025 | 2 Dec 2025 |
| Outcome of Board meeting under Regulation 30 of SEBI(Listing Obligations and disclosures Requirements), regulations 2015. | ||
| Board Meeting | 14 Nov 2025 | 10 Nov 2025 |
| Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve the Unaudited financials for the quarter ended on September 302025. Board meeting outcome as per regulation 30 and 33 of SEBI (Listing obligations and disclosures Requirements) Regulations ,2015-inter-alia to consider and approve the unaudited financial results for the quarter and half year ended on 30th september,2025 (As per BSE Announcement dated on: 14.11.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
